Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes

Abstract

BackgroundObesity and type 2 diabetes (T2D) are linked both with host genetics and with environmental factors, including dysbioses of the gut microbiota. However, it is unclear whether these microbial changes precede disease onset. Twin cohorts present a unique genetically-controlled opportunity to study the relationships between lifestyle factors and the microbiome. In particular, we hypothesized that family-independent changes in microbial composition and metabolic function during the sub-clinical state of T2D could be either causal or early biomarkers of progression.MethodsWe collected fecal samples and clinical metadata from 20 monozygotic Korean twins at up to two time points, resulting in 36 stool shotgun metagenomes. While the participants were neither obese nor diabetic, they spanned the entire range of healthy to near-clinical values and thus enabled the study of microbial associations during sub-clinical disease while accounting for genetic background.ResultsWe found changes both in composition and in function of the sub-clinical gut microbiome, including a decrease in Akkermansia muciniphila suggesting a role prior to the onset of disease, and functional changes reflecting a response to oxidative stress comparable to that previously observed in chronic T2D and inflammatory bowel diseases. Finally, our unique study design allowed us to examine the strain similarity between twins, and we found that twins demonstrate strain-level differences in composition despite species-level similarities.ConclusionsThese changes in the microbiome might be used for the early diagnosis of an inflamed gut and T2D prior to clinical onset of the disease and will help to advance toward microbial interventions.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-016-0271-6) contains supplementary material, which is available to authorized users.

Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure

“…We observed that Ruminococcus torques , involved in mucus degradation and gut barrier dysfunction [58], positively correlated with the increase in SBP. Furthermore, both Eubacterium siraeum and A. finegoldii , known to trigger intestinal inflammation [59,60], positively correlated with SBP. Although further validation is needed, this suggests that certain gut bacteria may drive intestinal gut barrier dysfunction and inflammation, which was confirmed by measurement of plasma markers and gut-targetted proinflammatory cells (Figure 4).…”

A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition

“…43 Furthermore, in a study of the microbiome in new-onset CD, an exploratory analysis of genomes of organisms associated with CD identified a contribution to pathway components that included a zinc-dependent enzyme. 6 We therefore hypothesized that the SLC39A8 genetic variant identified in this study may affect CD susceptibility by altering the microbiome.…”

Precision medicine in diabetes: an opportunity for clinical translation

“…88 Previous profiles of the gut microbiome in T2D have found compositional changes between patients and healthy controls, showing increased capacity for oxidative stress resistance and a decreased capacity for flagellar assembly and riboflavin metabolism. 89,90 However, the human microbiome contains vast numbers of uncharacterized enzymes, limiting our functional understanding of this community and its effects on host health and disease.…”